Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI measures muscle to predict cardiac arrest recovery

NCT ID NCT07034170

Knowledge-focused Sponsor: National Taiwan University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study investigates whether muscle mass, measured automatically from CT scans using artificial intelligence, can help predict recovery in people who survive a cardiac arrest. Researchers will also test an enhanced rehabilitation program that includes muscle stimulation and guided exercise to see if it improves short- and long-term outcomes. The goal is to better understand how muscle health influences recovery after cardiac arrest.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Enhanced Rehabilitation Program (muscular electrical stimulation, guided active rehabilitation, structured physical engagement)
What this could lead to
If successful, this could lead to a simple way to predict recovery after cardiac arrest and a targeted rehab program to improve outcomes.
What could go wrong
This is a small, early-stage study. The AI tool and rehab program may not improve recovery in larger or more diverse groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 99 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Non-traumatic adult patients who experienced sudden cardiac arrest * Achieved sustained return of spontaneous circulation (ROSC) for more than five minutes following successful resuscitation * Admitted to the ICU * Survived beyond 72 hours without successful weaning from mechanical ventilation Exclusion Criteria: * Age under 18 years * Pregnancy * Expected to be weaned from mechanical ventilation within 48 hours * Terminal-stage cancer or unwillingness to receive aggressive treatment * Unavailability of ICU care due to overcrowding in the emergency intensive care unit * Refusal to participate in the study by the patient or family members * Presence of an implanted pacemaker or defibrillator * Open wounds, severe edema, or deep vein thrombosis in the lower limbs * Pre-arrest status limited to wheelchair use or bedridden, unable to ambulate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Inhospital cardiac arrest are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cardiac arrest Out-of-Hospital Cardiac Arrest

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Inhospital cardiac arrest Out-of-hospital cardiac arrest

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department of Emergency Medicine, National Taiwan University Hospital

    Taipei, Taipei, 100, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.